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Diastrophic dysplasia: prenatal diagnosis and review of 
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ABSTRACT
CONTEXT: Diastrophic dysplasia is a type of osteochondrodysplasia caused by homozygous muta-
tion in the gene DTDST (diastrophic dysplasia sulfate transporter gene). Abnormalities occurring 
particularly in the skeletal and cartilaginous system are typical of the disease, which has an inci-
dence of 1 in 100,000 live births. 
CASE REPORT: The case of a pregnant woman, without any consanguineous relationship with her hus-
band, whose fetus was diagnosed with skeletal dysplasia based on ultrasound findings and DNA tests, is 
described. An obstetric ultrasound scan produced in the 16th week of gestation revealed characteristics 
that guided the clinical diagnosis. Prominent among these characteristics were rhizomelia of the lower 
and upper limbs (shortening of the proximal portions) and mesomelia (shortening of the intermediate 
portions). Both upper limbs showed marked curvature, with the first finger of the upper limbs in abduction 
and clinodactyly of the fifth finger. Molecular analysis using the polymerase chain reaction (PCR) and gene 
sequencing detected mutations that had already been described in the literature for the gene DTDST, 
named c.862C > T and c.2147_2148insCT. Therefore, the fetus was a compound heterozygote, carrying 
two different mutations. 
CONCLUSIONS: Prenatal diagnosis of this condition allowed a more realistic interpretation of the progno-
sis, and of the couple’s reproductive future. This case report shows the contribution of molecular genetics 
towards the prenatal diagnosis, for which there are few descriptions in the literature.
RESUMO
CONTEXTO: A displasia diastrófica é uma osteocondrodisplasia causada por mutação homozigótica no gene 
DTDST (diastrophic dysplasia sulfate transporter gene). As alterações, principalmente nos sistemas esquelético 
e cartilaginoso, são típicas dessa doença, que tem uma incidência de 1 em 100.000 nascidos vivos. 
RELATO DO CASO: Descreve-se o caso de uma mulher gestante, sem relação consanguínea com o seu 
marido, cujo feto foi diagnosticado com displasia esquelética baseado na ultrassonografia e em testes de 
DNA. A ultrassonografia obstétrica, realizada na 16a semana, revelou características que guiaram o diag-
nóstico clínico. Entre elas, se destacam os membros inferiores e superiores com rizomelia (encurtamen-
to das porções proximais) e mesomelia (encurtamento das porções intermediárias), ambos os membros 
superiores mostraram acentuada flexão, o primeiro dedo em abdução nas extremidades superiores e 
clinodactilia do quinto dedo. A análise molecular pela reação em cadeia da polimerase (PCR) e o sequen-
ciamento gênico detectou mutações já descritas na literatura para o gene DTDST, chamado c.862C > T e 
c.2147_2148insCT. Portanto, o feto é um heterozigoto composto, carreando duas mutações diferentes. 
CONCLUSÕES: O diagnóstico pré-natal dessa condição permite uma interpretação mais realista do prog-
nóstico e do futuro reprodutivo do casal. Este relato de caso mostra a contribuição da genética molecular 
no diagnóstico pré-natal, com poucas descrições na literatura.
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INTRODUCTION
Diastrophic dysplasia (DTD) is a type of congenital osteochon-
drodysplasia with an autosomal recessive inheritance pattern, 
first described by Lamy and Maroteaux in 1960. In general, 
osteochondrodysplasias are changes to the skeletal system that 
produce bone remodeling, cartilage and growth disorders. They 
are characterized by micromelia dwarfism, progressive scoliosis, 
bilateral talipes equinovarus, multiple digital deformities (short 
fingers, synostosis of proximal interphalangeal joints, abnor-
mal thumb insertion and a thumb known as a “hitchhiker”, posi-
tioned as in the act of hitchhiking, due to deformity of the first 
metacarpus), short stature (the reason why the disease is also 
called diastrophic dwarfism), characteristic ear deformities and, 
occasionally, a cleft palate. The term diastrophic is appropriate, 
because it comes from the Greek word diastrophos, which means 
twisted or bent.1,2
DTD is an unusual type of dwarfism. It has been observed 
in most white populations, but is notably more prevalent among 
Finns. In Finland, 1-2% of the population carries a mutation 
in the DTD gene (DTDST), with an incidence of 1 in 33,000 
births. In the United States, the incidence is 1:500,000 births. In 
1990, there were 160 Finn patients with a confirmed diagnosis 
of skeletal dysplasia, while there were fewer than 300 patients in 
the rest of the world.3-5 
During the formation of the skeletal system, most of the 
bones originate from the cartilage, in a process called endochon-
dral ossification. This process allows elongation and thicken-
ing of the bones as the fetus grows, and it continues throughout 
childhood until bone growth ceases.6 In adults, cartilage is pres-
ent in the ribs, outer ear, airways and joints, in which it has a sup-
port function. Cartilage is essential for growth and support of 
the human skeletal system. Its biological characteristics depend 
mainly on the cartilage matrix, which is composed of cartilage-
specific collagen and sulfated proteoglycans. Proteoglycans are 
a family of macromolecules formed by chains of core proteins 
that covalently bind glycosaminoglycans (GAGs), which are large 
unbranched polysaccharide chains that are classified into four 
groups: (a) chondroitin sulfate and dermatan sulfate; (b) heparin 
sulfate and heparin; (c) keratin sulfate; and (d) hyaluronic acid. 
The first three groups undergo sulfation and bind to proteins to 
form proteoglycans. The four groups are distributed heteroge-
neously in various tissues such as cartilage, synovial fluid, con-
nective tissue, skin and lungs.5,7,8 
The diastrophic dystrophy sulfate transporter (DTDST) 
gene, also known as SLC26A2 (solute carrier family Homo 
sapiens 26), encodes a membrane sulfate transporter anion 
protein that is necessary for sulfation of the GAGs that form 
proteoglycans, which comprise the cartilage matrix. The pro-
tein performs exchanges between sulfate and chloride ions. 
Sulfation of GAGs makes them negatively charged and con-
tributes towards their ability to retain sodium and water, 
thereby maintaining the hydration of the cartilage matrix 
and contributing towards its property of impact absorption. 
Skeletal dysplasia occurs as result of a mutation that changes 
the process of sulfation, which interferes with endochondral 
ossification and, hence, the formation of the skeleton and lin-
ear growth.3,7-10
Molecular characterization of mutations in the DTDST gene
In 1991, Hästbacka et al.11 elucidated the structure of the 
DTDST gene, which consists of three exons. Two of these are 
coding exons; they are separated by an intron of approximately 
1.8 kb and encode a protein of 739 amino acids that forms 12 
transmembrane domains and a carboxy-terminal cystoplasmic 
residue. The gene is located on the long arm of chromosome 
5q.31-q.34.7,10 Mutations of the DTDST gene are responsible 
for four clinical manifestations of chondrodysplasia: “classic” 
diastrophic dysplasia (DTD), multiple epiphyseal dysplasia 
4 (MED 4), atelosteogenesis type II (AO-II) and achondroplasia 
type 1B (ACG-1B).2,3 ACG-1B is the most severe form of chon-
drodysplasia and is usually lethal before birth or soon after. It is 
one of the most severe skeletal disorders in humans, character-
ized by severe hypodysplasia of the spine, chest and limbs. AO-II 
is a form of chondrodysplasia with clinical and histopathologi-
cal manifestations similar to the ones found in DTD, but which 
are more pronounced. Death often occurs during the neonatal 
period. MED 4 is considered to be the mildest form and is char-
acterized by joint pain (usually in the hips and knees), deformi-
ties of the hands, feet and knees, and scoliosis.2-4
Mutations in the DTDST gene were evaluated by Karnisk through 
the techniques of direct immunofluorescence, immunoblotting and 
densitometry, by transfection of mutated genes in human embryonic 
kidney cells (HEK 293). Correlations of these results with the muta-
tions shown in patients with different clinical forms of chondrodys-
plasia were evaluated. From this, amino acid substitution mutations 
in the cytoplasmic domain of the protein, encoded by DTDST gene, 
were seen to partially maintain protein activity (A715V, R279W, 
Q454P and C653S) or showed no protein function because of lack 
of adequate expression in the cell membrane (G678V). Mutations 
that occurred in the transmembrane domains (DV340, N425D and 
L483P) or that encoded premature stop codons during translation 
(R178X, Δa1751) were responsible for severe alterations in protein 
structure, which did not allow transportation of significant quanti-
ties of sulfate when expressed in mammalian cells.12 Karnisk evalu-
ated the connection between genotype/phenotype and the protein 
activity encoded by the DTDST gene. Patients with the most severe 
form (ACG-1B) showed null mutation in both alleles (sulfate trans-
portation rate less than 10%). For moderate-severity clinical forms 
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(AOII and DTD), null mutation was observed in one allele and a 
mutation that partially preserved the protein function in the other 
allele. Homozygotes for mutations that retained partial function 
were characterized by the mild form (MED-4), which expressed 
protein activity of between 39 and 62%.12
It is also important to take into account intron mutations, 
which were not reported in Karnisk’s study. These can lead 
to a low rate of messenger RNA (mRNA) expression, through 
changes to the process of intron excision and, consequently, may 
reduce the rate of adequate protein formation. Mutation IVS1+2 
T > C is an example of a mutation located in intron 1. Patients 
who are homozygous for this kind of mutation, or who are com-
pound heterozygous with one of the alleles with R279W muta-
tion, show clinical conditions similar to DTD or MED 4.2,10,12
Diagnosis
The combination of clinical, radiological and histopatholog-
ical characteristics in diastrophic dysplasia allows diagno-
sis at birth. According to a study conducted at the Instituto da 
Criança, Hospital das Clínicas (HC), Faculdade de Medicina 
da Universidade de São Paulo (FMUSP), by Gonzales and 
Marcondes,1 the presence of micromelia, congenital clubfoot 
and  digital deformities, especially the thumb in permanent 
abduction, facilitates recognition of this pathological condition. 
Birth weight is normal, while stature is greatly diminished (it has 
been reported that adults with DTD have an average height of 
135.7 cm for men and 129.0 cm for women.1 In 85% of the cases, 
the ears may appear suddenly inflamed and swollen over the first 
weeks of life. This inflammation persists for several weeks and 
may leave the ear thickened, hard and with irregular morphol-
ogy, known as a “cauliflower ear”. The external ear canal is nar-
row, but generally the hearing is not affected. The head and skull 
are normal, but the face tends to be square, with narrow nose at 
the proximal end and large at the middle portion. A cleft palate is 
found in approximately one quarter of the cases.1,5
Prenatal diagnosis is possible by means of ultrasound and 
molecular analysis. Ultrasound in the second trimester allows sus-
picion of the disease when the limbs are shorter than normal. One 
important characteristic observed in fetuses with diastrophic dys-
plasia is the preserved relationship between the thoracic and waist 
circumferences. Moreover, the presence of the first finger in abduc-
tion is quite specific.13,14 DNA analysis can be done by extracting 
genetic material from fetal cells obtained by chorionic villus sam-
pling or amniocentesis. Molecular analysis on the parents is done 
through collection of genetic material from leukocytes.
Hästbacka et al.15 used DNA markers to predict the geno-
types of five fetuses in families with previous histories of DTD. 
The results predicted that three would not be affected and two 
would. These results were concordant with those obtained from 
ultrasound, and the fetal phenotype was correctly predicted in all 
cases. DNA analysis is the most reliable means for prenatal diag-
nosis in the first trimester of pregnancy. 
Prognosis and treatment
During the neonatal period, the mortality rate is high (25%), 
usually caused by airway obstruction. If patients survive this 
period, the prognosis is favorable. Their mental and sexual 
development are normal.2,7
The treatment for patients with diastrophic dysplasia con-
sists of physiotherapy and other correlated therapies that help 
to improve mobility. Surgical treatment of clubfoot is indi-
cated when the deformity makes walking impossible. The rate 
of spontaneous correction of cervical kyphosis is high, and 
cervical spinal surgery among children may be restricted to 
individuals with clinical or neurophysiological evidence of 
spinal shock. According to Helenius et al.,16 arthroplasty is 
indicated for “relatively young adults” with premature degen-
erative arthrosis. Clinicians should monitor patients’ spinal 
curvature annually, and their habits in order to avoid develop-
ment of excess weight (obesity), so that the patients’ joints are 
not subjected to unnecessary exertion.2 
OBJECTIVES
This study aimed to evaluate the ultrasound and molecular 
aspects of the prenatal diagnosis of diastrophic dysplasia, with 
a review of the literature on this genetic disorder.
Sources 
For the review, we used University textbooks relating to this topic 
and researched in the PubMed/Medline, Embase and Lilacs data-
bases. The search in PubMed/Medline and Embase were based 
on key words such as diastrophic dysplasia, prenatal, pregnancy, 
abduction of the first finger, ultrasound and DTDST gene. The 
search in Lilacs was based on key words such as displasia fibrosa 
óssea, displasia fibrosa ósea, diastrophic dysplasia, (diagnóstico 
pré-natal, prenatal diagnosis, atención prenatale) and (frequencia 
do gene, frecuencia de los genes, mutation, mutação).
The patient of this case report agreed to participate in this 
study, through signing a free and informed consent statement. 
This project was approved by the Research Ethics Committee of 
Faculdades Integradas do Brasil (UniBrasil), Curitiba, Paraná, in 
accordance with the regulations of the National Research Ethics 
Commission (Comissão Nacional de Ética em Pesquisa, Conep), 
through opinion report 035/2009.
CASE REPORT
The patient AJDR was 29 years of age (G3, P0, A2), and was seen 
at 16 weeks and six days of gestation. She and her husband were 
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phenotypically normal and not consanguineous. The patient said 
that she had not used warfarin during the first trimester of preg-
nancy. The routine ultrasound revealed that the fetus had short 
limbs, and the patient was then referred for an evaluation with 
a geneticist and specialist in fetal medicine. Detailed ultrasound 
examination (described below) showed signs suggestive of DTD, 
and amniocentesis was then performed to search for possible pres-
ence of mutations in the DTDST gene. Fetal morphological anal-
ysis revealed that the ossification of the skull and brain structure 
appeared to be normal. Although the lips and nose were normal, 
the facial profile showed micrognathia and the nasal bone was 
at the 10th percentile for the gestational age. The heart examination 
was unremarkable. In both the upper and the lower limbs, rhizo-
melia (shortening of proximal portions) and mesomelia (shorten-
ing of medial portions) were observed. Both upper limbs  showed 
marked curvature (campomelia). In the upper limbs, the thumb 
was observed to be in abduction, with clinodactyly of the  fifth 
finger (Figure 1, above). No other abnormalities were detected. 
The findings were compatible with fetal skeletal dysplasia.
The child of this case (a boy) was born on November 28, 2009, 
weighing 2.895 kg and with a length of 41 cm (Figure 2). He pre-
sented some difficulty in breathing that resolved without the need 
for mechanical ventilation. At first, the feet were not so crooked 
(equinovarus feet) and the initial treatment was with correction 
boots. As expected, the thumb was in abduction and the limbs 
were shorter. He was also born with hemangioma on the nose 
and forehead, another common finding in this dysplasia. No dis-
locations were observed in the clinical examination. Thus, it was 
believed that, as expected, the prognosis would be good. 
After the suspicion of a probable case of diastrophic dysplasia 
had been raised from the ultrasound image, the pregnant woman 
was referred to a genetic counseling center and molecular genetics 
laboratory for a prenatal molecular diagnosis to be made and for 
genetic counseling to be offered. According to the family pedigree 
(Figure 3), the parents were carriers of the DTDST gene (line II 
in Figure 3). The fetus was a compound heterozygote, carrying two 
different mutations (line III). The black balls (line III) indicate 
two previous miscarriages. The patient said that she had one brother 
Figure 2. Newborn with diastrophic dysplasia: the first finger can be 
seen to be in abduction, which is a typical alteration of this pathological 
condition.
Figure 1. Prenatal ultrasonography findings of diastrophic dysplasia: (a) clubfoot; (b) fifth finger with clinodactyly. 
A B
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and that her father had died. The husband had a brother and a sister, 
and both parents were alive. There was no reported family history of 
skeletal dysplasia in either of the families. 
The patient had had two previous miscarriages. When she was 
at 20 weeks of gestation, amniocentesis was performed in order to 
carry out genetic tests. Through this procedure, amniocyte DNA was 
extracted and DTDST locus amplification was performed by means 
of PCR on three coding exons from the DTDST gene. Two muta-
tions were detected: the transition c.862C > T (R279W) in exon 3, 
converting the arginine codon (CGG) to tryptophan codon (TGG); 
and c.2147_2148insCT in exon 3, in the DTDST gene. The second 
of these mutations, which involves insertion of two bases, causes a 
change in the reading frame and may result in aberrations in mRNA 
splicing. Both of these mutations had previously been described in 
the literature as pathogenic mutations of the DTDST gene.10
DISCUSSION
In this case report, the genetic pathological condition was iden-
tified in one allele of the DTDST gene in each member of this 
phenotypically normal couple: the father was heterozygous for 
the mutation c.862C > T and the mother was heterozygous for the 
mutation c.2147_2148insCT. 
Differentiation of DTD from superficially similar forms of 
dwarfism, especially achondroplasia, is important because of 
the greater morbidity, greater difficulty in case management and 
poorer reproductive prognosis for the parents in cases of DTD. 
Achondroplasia is a form of dwarfism produced by changes in 
growth due to deficiency of endochondral ossification, caused by 
mutation in the gene located at 4p16.3, which is responsible for 
synthesis of receptor 3 for fibroblast growth factor. A patient with 
achondroplasia, born from normal parents, is usually the result 
from a new mutation. The risk of recurrence is very low in this, 
while in diastrophic dwarfism it is 25%. Several errors in genetic 
counseling have been committed because of confusion between 
these two diseases. Recently, with the advent of prenatal molecu-
lar diagnosis, there has been a reduction in diagnostic errors. It 
has been recommended that families should be assisted through 
genetic counseling and that appropriate clinical measures should 
be established early on.2
According to Rossi and Superti-Furga, the muta-
tion c.862  C  >  T  (R279W) is the most common mutation in 
Caucasians. This is characterized by substitution of a cytosine by 
a thymine, thus causing a reading change from the amino acid 
codon arginine to a tryptophan. Homozygotes of this mutation tend 
to have the milder manifestations of dysplasia (MED4), while retain-
ing some residual activity. Since the mutation c.2147-2148insCT, 
common in French descendants, encodes a premature stop codon 
during translation, this mutation in homozygous cases is related to 
achondroplasia type 1B.10
The fetus in the present case was diagnosed with a “classical” 
form of diastrophic dysplasia, showing a mutation that retained 
partial activity (R279W) and a mutation that led to loss of func-
tion (c.2147-2148insCT, a null mutation). This genotype suggested 
that 50% of the protein production had retained its activity, which 
agrees with data in the literature confirming that individuals with 
DTD or AO-II (classical) have a mutation in one allele that retains 
partial activity, with loss of protein function by the other allele.10,12
As shown in Table 1, there have only been seven case reports 
of DTD diagnosed by means of prenatal ultrasound.1,3,15,17-20 
Moreover, the present case report is only the second in the lit-
erature in which prenatal ultrasound and molecular DNA 
analysis were used for diagnosing DTD.15 Unlike the study by 
Table 1. Systematic review of the literature*
Database Search strategy Results
Medline/PubMed
(Diastrophic dysplasia) AND (Prenatal diagnosis) AND (Abduction of the first finger) 




Embase (Diastrophic dysplasia) AND (Prenatal diagnosis) AND (Abduction of the first finger) 
AND (Ultrasound) AND (DTDST gene)
No original articles, case reports
or review articles
Lilacs ((Displasia fibrosa óssea) OR (Diastrophic dysplasia)) AND ((Diagnóstico pré-natal) 
OR (Prenatal diagnosis) OR (Atención prenatale)) AND ((Frequencia do gene) OR 
(Frecuencia de los genes) OR (Mutation OR Mutação))
2 case reports
1 review
*The search in these databases was conducted on April 2, 2011. 
Figure 3. Pedigree of the family of this study.
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Hästbacka et al.,15 in which five fetuses from families with previ-
ous histories of DTD were assessed, in our case report the couple 
did not have a consanguineous relationship and there was no pre-
vious history of DTD in their families.
CONCLUSION
Prenatal diagnosis of diastrophic dysplasia during the second tri-
mester of pregnancy has fundamental implications for the prog-
nosis, and enables earlier clinical guidance and genetic coun-
seling. Identification of the DTDST gene in the 1990s has make 
molecular diagnosis reliable for most families with a positive his-
tory, and even for families without other family cases, as shown 
in this report. We emphasize that this study is important because 
it presents a case in which the diagnosis was confirmed prena-
tally through molecular analysis, given that in the literature there 
is only one other case report of a diagnosis confirmed by prenatal 
molecular analysis.15
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